Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

PhishPharm - Detail
  • Print
  • Share
  • E-mail
-
 
Title:  Randomized clinical trial to investigate the effectiveness of teflubenzuron for treating sea lice on Atlantic salmon.
 
Authors:  Campbell PJ, Hammell KL, Dohoo IR, Ritchie G
 
Drug:  Teflubenzuron
 
Fish species:  Salmon, Atlantic
 
Date:  2006
 
Sample:  skin+parasites
 
Ave Weight (gm):  3.27
 
Ave Water temp (°C):  12.1
 
Water:  Saltwater
 
Dosage:  10 mg/kg 7d
 
Route:  PO
 
Comments:  Sea lice (chalimus stages) were significantly lower than control cages at week 1 (79%) and week 2 (53%). Mobile adult stages were also reduced by 69% and 40% in week 1 and 2 respectively. Most effective against chalimus stages. Double blind randomized clinical trial in Good Clinical Practice (GCP). 3 sites.
 
Citation:  Diseases of Aquatic Organisms 70:101-108
 
Link:  http://www.int-res.com/abstracts/dao/v70/n1-2/p101-108/  Opens a new window
 
Genus Species:  Salmo salar
 
Drug Class:  Insecticide-Teflubenzuron
 
Water temp (°C)-detail:  11.7-13.1 C
 
Dosage-detail:  10 mg/kg 7d
 
Method:  Visual
 
Authors-red:  Campbell PJ, Hammell KL, Dohoo IR, Ritchie G
 
-
-